Newronika announced today that it received CE mark approval for its AlphaDBS device for treating Parkinson's disease.
Enable Injections’ enFuse Syringe Transfer System has secured CE mark approval under the European Union Medical Device ...
Newronika has secured CE Mark approval for its AlphaDBS device aimed at the treatment of Parkinson's disease (PD), in Europe.
Enable Injections announced today that it received CE mark approval for its EnFuse syringe transfer system for drug delivery.